Weekly review: Deli meats linked to listeria outbreak, roflumilast foam 0.3% sNDA submission and more
Get caught up with our journal! Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.
Food Insecurity and the Dangers of Infant Formula Dilution
FDA grants RPDD to CSTI-500 for treating pediatric Prader-Willi Syndrome
ConSynance Therapeutics' CSTI-500, an innovative Triple Monoamine Reuptake Inhibitor, has received FDA's Rare Pediatric Disease Designation for treating Prader-Willi Syndrome in children.
Demystifying Infant Formula
FDA expands maralixibat label to include PFIC patients aged 12 months and older
Initial approval for maralixibat was granted on March 13, 2024, to treat PFIC patients aged 5 years and older.
Air pollution exposure during pregnancy linked to reduced lung function in childhood
These data highlighted the association of moderate air pollution exposure during pregnancy, infancy, and early childhood on pulmonary function at school age.
